Predicting response to abiraterone acetate (AA): mRNA biomarker analysis of study COU-AA-302.
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Deborah Sokol Ricci, Weimin Li, Thomas W. Griffin, Michael Gormley, Erin Henitz, Charles J. Ryan, Johann Sebastian De Bono, Gerhardt Attard, Alfons JM van den Eertwegh, Dirk L. Schrijvers, John J. Gullo, Henrik Suttmann, Joan Carles, Jose Maria Piulats Rodriguez, Robert J. Jones, Christopher Logothetis, Dana E. Rathkopf, Howard I. Scher, Eleni Efstathiou
Institutions: Janssen Research & Development (United States), University of California, San Francisco, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, Amsterdam UMC Location Vrije Universiteit Amsterdam, ZNA Middelheim Hospital, Ziekenhuisnetwerk Antwerpen Stuivenberg, Hematology Oncology Associates of Central New York, Vall d'Hebron Hospital Universitari, Institut Català d'Oncologia, Beatson West of Scotland Cancer Centre, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2486156529